EUVIMEDEUVIMED entdecken
Crossref

POU2F2-mediated Upregulation of lncRNA PTPRG-AS1 Inhibits Ferroptosis in Breast Cancer Via miR-376c-3p/SLC7A11 Axis

Jun Li iD, Pei-Ting Li iD, Wei Wu iD, Bo-Ni Ding iD, Yan-Guang Wen iD, Hai-Lin Cai iD, Shuang-Xi Liu iD, Tao Hong iD, Jian-Fei Zhang iD, Jian-Da Zhou iD, Li-Yuan Qian iD, Juan Du iD

Epigenomics · 2024-02 · 16 (4) · 215-231

DOI: 10.2217/epi-2023-0100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epigenomics, online erschienen am 06.02.2024. Verfasst von Jun Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast & Thyroid Surgery, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan Province, China. Hauptthemen laut MEDLINE: Ferroptosis, MicroRNAs, Octamer Transcription Factor-2, RNA, Long Noncoding. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Triple-negative breast cancer (TNBC) is a subtype of BC with high rates of mortality. The mechanism of PTPRG-AS1 in ferroptosis of TNBC was investigated.

Methods

Chromatin immunoprecipitation and dual-luciferase reporter assays were used to measure intermolecular relationships. MTT and colony formation assays detected cell viability and proliferation. Kits detected Fe2+ and reactive oxygen species levels. The role of PTPRG-AS1 in tumor growth was analyzed in vivo.

Results

PTPRG-AS1 was increased in TNBC tissues and cells. PTPRG-AS1 silencing increased the reduction of glutathione and GPX4, increased Fe2+ and reactive oxygen species in erastin-treated cells and inhibited proliferation. POU2F2 transcriptionally upregulated PTPRG-AS1. PTPRG-AS1 targeted miR-376c-3p to upregulate SLC7A11. PTPRG-AS1 knockdown suppressed tumor growth in vivo.

Conclusion

POU2F2 transcriptionally activates PTPRG-AS1 to modulate ferroptosis and proliferation by miR-376c-3p/SLC7A11, promoting TNBC. Triple-negative breast cancer (TNBC) is a kind of breast cancer with high recurrence and low survival rates. Activation of the ferroptosis pathway can inhibit BC proliferation and distant metastasis. Therefore, identifying effective biomarkers and molecular mechanisms of ferroptosis in TNBC is important for its earlier detection and therapy. PTPRG-AS1 is a new type of lncRNA discovered in recent years that is increased in various diseases and is related to prognosis. In the present study, the authors found that POU2F2 promoted PTPRG-AS1 transcription. PTPRG-AS1 knockdown activated ferroptosis in TNBC and inhibited proliferation. Mechanistically, PTPRG-AS1 targeted miR-376c-3p to upregulate SLC7A11, thereby inhibiting ferroptosis and promoting TNBC development. These results indicate that PTPRG-AS1 is a possible therapeutic target in TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisMicroRNAsOctamer Transcription Factor-2RNA, Long NoncodingTriple Negative Breast NeoplasmsHumansAmino Acid Transport System y+Cell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticReactive Oxygen SpeciesReceptor-Like Protein Tyrosine Phosphatases, Class 5Up-Regulation

Stichwörter der Autor:innen

SLC7A11breast cancerferroptosislncRNA PTPRG-AS1

Substanzen

Amino Acid Transport System y+MicroRNAsOctamer Transcription Factor-2POU2F2 protein, humanPTPRG protein, humanReactive Oxygen SpeciesReceptor-Like Protein Tyrosine Phosphatases, Class 5RNA, Long NoncodingSLC7A11 protein, humanMIRN376C microRNA, human

Autor:innen und Institutionen

  • Department of Breast & Thyroid Surgery, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan Province, China.
  • Department of Breast & Thyroid Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, 330008, Jiangxi Province, China.
  • Department of Plastic Surgery, The Second Affiliated Hospital of the University of South China, Hengyang, 421000, Hunan Province, China.
  • Department of Plastic Surgery, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan Province, China.

ORCID-Profile: Jun Li, Pei-Ting Li, Wei Wu, Bo-Ni Ding, Yan-Guang Wen, Hai-Lin Cai, Shuang-Xi Liu, Tao Hong, Jian-Fei Zhang, Jian-Da Zhou, Li-Yuan Qian, Juan Du

Förderung

  • Natural Science Foundation of Hunan Province, China

Zitieren

APA

Li, J., Li, P. T., Wu, W., Ding, B. N., Wen, Y. G., Cai, H. L., Liu, S. X., Hong, T., Zhang, J. F., Zhou, J. D., Qian, L. Y., & Du, J. (2024). POU2F2-mediated Upregulation of lncRNA PTPRG-AS1 Inhibits Ferroptosis in Breast Cancer Via miR-376c-3p/SLC7A11 Axis. Epigenomics, 16(4), 215-231. https://doi.org/10.2217/epi-2023-0100

Vancouver

Li J, Li PT, Wu W, Ding BN, Wen YG, Cai HL, et al. POU2F2-mediated Upregulation of lncRNA PTPRG-AS1 Inhibits Ferroptosis in Breast Cancer Via miR-376c-3p/SLC7A11 Axis. Epigenomics. 2024;16(4):215-231. doi:10.2217/epi-2023-0100

BibTeX
@article{Li2024,
  author = {Li, Jun and Li, Pei-Ting and Wu, Wei and Ding, Bo-Ni and Wen, Yan-Guang and Cai, Hai-Lin and Liu, Shuang-Xi and Hong, Tao and Zhang, Jian-Fei and Zhou, Jian-Da and Qian, Li-Yuan and Du, Juan},
  title = {POU2F2-mediated Upregulation of lncRNA PTPRG-AS1 Inhibits Ferroptosis in Breast Cancer Via miR-376c-3p/SLC7A11 Axis},
  journal = {Epigenomics},
  year = {2024},
  volume = {16},
  number = {4},
  pages = {215--231},
  doi = {10.2217/epi-2023-0100}
}
Kostenlos starten →